In California, Antitrust Claims Over Patent Settlements Survive

Mealey's (March 5, 2020, 1:40 PM EST) -- SAN FRANCISCO — Allegations of antitrust violations by a putative class in connection with patent settlement agreements between the makers of combination antiretroviral therapy (cART) drugs for the treatment of HIV...
To view the full article, register now.